.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Citi
Harvard Business School
McKinsey
Baxter
Farmers Insurance
QuintilesIMS
US Army
Johnson and Johnson
Medtronic

Generated: September 20, 2017

DrugPatentWatch Database Preview

Teva Parenteral Company Profile

« Back to Dashboard

What is the competitive landscape for TEVA PARENTERAL, and what generic and branded alternatives to TEVA PARENTERAL drugs are available?

TEVA PARENTERAL has forty-eight approved drugs.

There are six tentative approvals on TEVA PARENTERAL drugs.

Summary for Applicant: Teva Parenteral

Patents:0
Tradenames:40
Ingredients:38
NDAs:48
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Parenteral
SUMATRIPTAN SUCCINATE
sumatriptan succinate
INJECTABLE;SUBCUTANEOUS078318-001Feb 6, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
NEOSAR
cyclophosphamide
INJECTABLE;INJECTION040015-005Apr 29, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
DAUNORUBICIN HYDROCHLORIDE
daunorubicin hydrochloride
INJECTABLE;INJECTION064212-002May 3, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
HYDRALAZINE HYDROCHLORIDE
hydralazine hydrochloride
INJECTABLE;INJECTION040373-001Feb 23, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
FLUPHENAZINE DECANOATE
fluphenazine decanoate
INJECTABLE;INJECTION074795-001Sep 10, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
CLINDAMYCIN PHOSPHATE
clindamycin phosphate
INJECTABLE;INJECTION063041-001Dec 29, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
METHYLPREDNISOLONE SODIUM SUCCINATE
methylprednisolone sodium succinate
INJECTABLE;INJECTION081268-001Nov 30, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
CYTARABINE
cytarabine
INJECTABLE;INJECTION016793-003Dec 21, 1987DISCNYesNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
NEOSAR
cyclophosphamide
INJECTABLE;INJECTION040015-004Apr 29, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Parenteral
ATRACURIUM BESYLATE
atracurium besylate
INJECTABLE;INJECTION074784-001Jun 11, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Teva Parenteral

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Parenteral
CYTARABINE
cytarabine
INJECTABLE;INJECTION016793-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Teva Parenteral
CYTARABINE
cytarabine
INJECTABLE;INJECTION016793-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Dow
Federal Trade Commission
Deloitte
Novartis
Covington
Cipla
Farmers Insurance
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot